Figure 6.
Cumulative incidence of first biologic switch with competing risks of biologic discontinuation or inclusion in a clinical trial. *Number of patients free from any event. [Colour figure can be viewed at wileyonlinelibrary.com]
Cumulative incidence of first biologic switch with competing risks of biologic discontinuation or inclusion in a clinical trial. *Number of patients free from any event. [Colour figure can be viewed at wileyonlinelibrary.com]